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Abstract                                                                                                                                                                           
The study attempts to assess the channel performance of the vertical marketing system of drugs distribution in 
Abia State of Nigeria and the extent channel members’ satisfaction with the channel linkage can facilitate co-
operation among members. Two research questions were raised to guide the study. Two hypotheses were 
formulated for testing. A sample of 300 respondents, comprising 30 licensed drug manufacturers/ importers, 49 
wholesalers, 74 Retailers, and 147 Customers was selected from a population of 1200 respondents. 
Questionnaires were administered and completely retrieved. Interviews were held with some licensed 
distribution channel members. Data were analyzed using Z-test at 0.05 level of significance and 4 degrees of 
freedom. Findings revealed low performance of the vertical marketing system of drugs distribution and the 
statistical insignificance of the channel members’ satisfaction with the channel linkage in relation to facilitating 
co-operation among members. The manufactuturers should provide assistance to other channel members in 
training / retraining of personnel to enable them understand the total channel concept. They should extend credits 
provisions to other channel members while the wealthy distributors should make substantial financial deposits 
available to manufacturers to enable them attain economies of scale in production. These recommendations, 
among others, would enhance channel performance, improve channel members’ satisfaction with the channel 
linkage and induce the cooperation of members. 
Keywords:  Vertical Marketing System, Channel Performance, Channel Members’ Satisfaction, Dysfunctional 
Conflict, Metrics and Brand Equity. 
1. Background of the Study 
Medical drugs are chemical substances used in restoring abnormal physical state, correcting or modifying 
organic malfunctions in human beings or in animals or preventing any disease disorder (Okoye, 2005:44). The 
process of manufacturing and distributing medical drugs is similar to that of other consumer products. The 
crucial stage in this development process is distribution. It is the process of transfer from manufacturer to the 
consumers. The transfer is routed through the marketing or distribution channel. The distribution channel is the 
institution through which a company goes to market. It is a set of firms and individuals that take title or assist in 
transferring title to the consumer (Roller, 1980:50, cited in Chukwu, 2004:5). The drugs move from the 
manufacturers’ warehouses, wholesale distribution, retail pharmacies / chemists and finally to the consumers 
(patients). Bridging the gap between the production and consumption of goods and services constitute the main 
task of the channel of distribution. There are two types of distribution channel system available to the 
manufacturer, viz; direct and indirect. When the manufacturer sells direct to the consumers or industrial users, it 
is direct channel of distribution. There are no intervening middlemen between the manufacturer and the ultimate 
consumer. Indirect channel of distribution involves the use of intermediaries (channel members) to sell the 
products to the consumers through their own marketing contacts.  
The principal functions of the intermediaries include customer contact and selling, stockholding, delivery, credit 
provisions, product and customer servicing, promotion and information gathering, among others. Unlike the 
vertical marketing system, conventional or traditional system is made up of cluster of middlemen that perform 
conflicting functions. At times, the exact functions of these middlemen are difficult to understand. The 
manufacturer may not even present himself as a channel member but simply sells his drugs to the middlemen 
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and is uninterested in the total channel concept. The manufacturer may even bypass the registered wholesalers 
and sell direct to institutional buyers, creating channel conflicts. Today the situation is changing as each channel 
member realizes that his success is affected by the performance of the entire marketing channel (Chukwu, 
2004:334). This vertical marketing system is a formally or informally coordinated distribution channel where its 
independent members work together to achieve greater efficiency and economies of scale and to eliminate 
channel conflicts arising out of desperate individual objectives 
(http://www.businessdictionary.com/definition/vertical market system-VMS).It provides improved coordination 
of channel functions, cooperation of channel members and ensures membership loyalty through the use of 
specific programmes like credit provisions, drug return policy, prompt order processing/payment, sales force 
training and reduction of number of middlemen in a territory. The various forms of vertical marketing system 
include; Corporate, Administered and Contractual system. When the channels are jointly owned and each firm in 
the chain continues to perform a separate task, the vertical marketing system is corporate. When one powerful 
channel member co-ordinates the activities of the other channel members without an ownership stake, the 
marketing system is administered. The contractual vertical marketing system consists of independent production 
and distribution firms that formally agree to integrate their resources for mutual benefits.  
 
1.1 Statement of the problem.      
Ideally, a channel structure is supposed to be made up of different middlemen that perform different functions 
which in turn lead to efficiency in the distribution system (Chukwu, 2004:317). An understanding of the 
respective channel members’ functions, needs, attitudes and expectations concerning the operations of the 
channel prompts effective channel management. It provides insights for each channel member to anticipate the 
behavior of the other channel members and lead to the reduction of dysfunctional channel conflicts which 
enables the channel operate as a system. The choice of the structure of a channel of distribution raises the issue 
of whether the drug manufacturer or importer should completely decentralize or vertically integrate its channel 
of distribution. The decentralized channel of distribution(traditional marketing system) is highly fragmented with 
loose alignment of manufacturers, wholesalers and retailers, joined with each other at arm’s length and 
negotiates aggressively over terms of payment (Chukwu, 2011:333). They constitute cog in the wheels of 
efficient drugs distribution in Nigeria and increase cost of distribution, resulting in higher prices of drugs. The 
vertically integrated channel of distribution is more coordinated, and has high level dependency, commitment 
and cooperation among channel members. The capacity of a particular channel member to influence the other 
members is measured in terms of the support or assistance he provides to them. The dimensions of the channel 
support include creating awareness, product innovations, prompt drugs delivery, relative pricing to allow for 
sustainable profitability, inducements that foster channel relationship, paving way for growth in market shares of 
members. The evaluation of channel members’ performance is also dependent on the information flow (Chukwu, 
2004: 35).  The channel member’s role in providing this support has been found to be positively related to other 
channel members’ satisfaction with the channel linkage (Hunt and Nevin, 1974, cited in Teas, Evans and Horrell, 
1974: 29-41). Channel performance relies on the understanding the manufacturer and middlemen have, 
concerning the nature of their relationship, mutual dependence, strengths, weaknesses and appropriate 
responsibilities (Grieve-Smith, 1985, cited in Shipley, 1985: 77).Since the promotion of cooperation among 
channel members is the antidote to conflict management. Marketing channel performance does not imply simply 
a trade-off for each channel member against the other members, rather every channel member should be able to 
achieve his objectives from the channel relationship. The vertical marketing system enables the channel 
members; producers, wholesalers, retailers and consumers, work together in harmony to overcome the time, 
space and possession gaps between production and consumption. It is designed to foster cooperation through 
channel members’ satisfaction and eliminates opportunism. The performance of this vertical marketing system of 
drugs distribution in Abia State, Nigeria  and the extent of channel members’ satisfaction with the distribution 
channel linkage, provide the stimuli for the current study. 
1.2 Objectives of the Study.                                      
  The broad objective of this study is to appraise the performance of the vertical marketing system of 
drugs distribution in Abia State, Nigeria. The specific objectives include; a) to assess the efficiency of the 
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vertical marketing system of drugs distribution. b) To evaluate the extent of channel members’ satisfaction with 
the drugs distribution channels linkage in relation to co-operation among members. 
1.3  Research Questions.                                                                                                                                                  
 The study attempts to provide answers to the following questions. 1) What is the performance of vertical 
marketing system of drugs distribution in Abia State?  2)To what extent has the channel members’ satisfaction 
with the distribution channel linkage enhanced co-operation among members? 
1.4   Research Hypotheses.                                                                                                                                               
 In course of this study, the following null hypotheses were formulated. 1) Ho:  The channel performance of the 
vertical marketing system of drugs distribution in Abia State is not significantly high. 2) Ho:   The extent of 
channel members’ satisfaction with distribution channel linkage is not significant to facilitate co-operation 
among members.  
1.5Significance of the Study.                                                                                                                                           
 The assessment of the channel performance of the vertical marketing system of drugs distribution constitutes the 
vision of this study. The study aims at; a) Encouraging channel members to improve their performance for 
mutual economic gains. b) Fostering beneficial relationships among personnel at different channel levels. c) 
Creating effective internal communication network that enables channel members understand their respective 
roles and functions. d) Creating distribution system that operates with minimum opportunism and reduced 
dysfunctional conflicts. 
2. Literature review.                             
Earlier approaches to the assessment of marketing or business performance focused on financial measures such 
as profitability, marginal revenue/marginal cost, cash flow potentials, budgeted variances and vertical integration 
measures, among others. Financial performance measures are necessary but not sufficient to define overall 
business performance (Ambler and Barwise, 1998, cited in Ambler and Kokkinaki, 1999:759). Marketplace 
measures which are essential to performance measurement cannot also be expressed in financial terms. A 
broader perspective in performance measurement has been advanced by many scholars. A performance model 
with increased customer satisfaction from improved product quality, leading in turn, to enhanced profitability 
was developed by Eccles and Pyburn (1992: 41-44). According to Murphy, Trailer and Hill (1996:15-23), 
majority of the performance measures have been found to be related to one of eight dimensions; Efficiency, 
Growth, Profit, Size, Liquidity, Success/ Failure, Market share and Leverage. Ambler and Kokkinaki (1999: 
755) stated that innovation is also an important dimension of marketing performance. Product, service and 
distribution innovations were found to provide ever fresh differentiation which caused competitors to be 
sustainably disadvantaged. The performance indicators may be measured indirectly through enhanced 
perceptions of customers and other stakeholders. In performance evaluation, bench marking constitutes a 
primary activity, involving both business results (e.g. profitability, quality) and processes (e.g. internal 
communications; Ambler and Kokkinaki, 1999:754). Bench marking involves multiple comparisons against past 
performance, business plan and goals set, performance and procedures of other units in the organization. The 
performance in any one period results partly from the marketing efforts of prior periods. In practical terms, 
performance needs to be at least compared internally with set plans and externally against the market as a whole 
(e.g., market share, relative price etc). There are two types of performance indicators, viz; short term, which 
delivers within the accounting period and brand equity stored for future periods. Brand equity is a set of assets 
and liabilities linked to a brand, its name and symbol that add to or subtract from the value provided by a product 
or service to a firm and or that firm’s customers. In empirical terms, brand equity measures the differential effect 
of brand knowledge on consumer response to the marketing of the brand (Kamakura and Russell, 1993: 9-22). 
The components of brand equity include; name awareness, perceived quality, brand associations and a bundle of 
intellectual properties such as patents, trademarks and channel relationship (Aaker, 1991: 15). The top level 
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marketing indicators for performance measurement are metrics. The indicators are precise and consistent and 
comprise market share, relative price, share of voice, brand loyalty and penetration. The principle demands that 
theory be used to build the list of metrics for consideration in any performance measurement (Ambler and 
Kokkinaki, 1999: 761). In practice, firms are encouraged to use combination of metrics that can most visibly be 
tracked and are capable of providing a reliable picture.  
The performance indicators used for this study include brand equity, prompt drug delivery, internal 
communication, relative prices, profitability, innovation, channel relationship and market share (growth). In 
assessing the channel members’ satisfaction with distribution channel linkage, a combination of metrics was 
applied, namely, prompt payment, credit provisions, mutual dependence, drugs return policy, avoidance of 
multiplicity of middlemen in a territory, training of sales force, reduction of dysfunctional conflicts and order 
processing. These performance indicators, including the metrics were measured indirectly by enhanced 
perceptions of the distribution channel members.   
    3.Methodology.                                                                                                                                                            
The study adopted survey research design. Both questionnaire and interview methods were used for data 
generation. The questionnaire applied the five point Likert Scale format, viz, strongly Agree(5points), 
Agree(4points),Undecided(3points),Disagree(2points),and Strongly Disagree(1point). The sampling method 
comprised stratified random sampling and judgmental techniques. The sample size was determined, using the 
formula developed by Yamane (1967, cited in Eboh 2009: 94).Mathematically, the formula is expressed as:  n   = 
N/1 + N (e2) ;where n =sample size, N=Actual Population, e=Level of significance (5%),  I=constant.The 
population of study, 1200 respondents, was drawn from the Pharmacists Council of Nigeria available lists of 
licensed drug firms in Abia State and major drug customers.  A sample size of 300 was derived. The 
questionnaire and interview questions were validated using the opinions of professionals in academics and 
industry. A pilot study involving 86 respondents was conducted to determine the reliability of the research 
instrument using Cronbach Alpha Technique. The reliability coefficient was 0.931, indicating high degree of 
internal consistency of the research instrument. The sample size for each sub-group of the drug firms was 
estimated using Bowley’s Proportional Allocation Technique; Nh = nNh/ N; where, nh=number of unit allocated 
to each sub-group, Nh=number of respondents in each sub-group, n=total sample size, N=total population. A 
total of 300 questionnaires were distributed in Aba, Umuahia, Ohafia and retrieved.The data generated were 
analyzed and the hypotheses tested using Z-Test Statistical Techique.         
 4.   Data Presentation and Analyses. 
The data generated from the survey were presented in tables and analyzed as shown below. 
Table 1. Population Distribution of Licensed Drugs Manufacturers/Importers, 
Wholesalers, Retailers and Major Drug Customers in Abia State.     
Channel  Members  Population  Percentages  
Manufacturers/ importers 120 10 
Wholesalers  196 16 
Retailers 295 25 
Customers 589 49 
Total 1200 100 
Source: Pharmacists’ Council of Nigeria, List of Licensed Pharmacies and Pharmaceutical Premises, as modified 
to include major drug customers of the retail firms, for the purpose of this study. 
Table 1 showed the population of study as 1200, comprising manufacturers/ importers (120), wholesalers (196), 
retailers (295) and major customers of each of the retail firms (589). The licensed drug firms and major 
customers of the retail firms constituted fifty one percent and forty-nine percent respectively of the study 
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population.Using Bowley’s formula, the sample size for each stratum was calculated and the results were; 
manufacturers/importers 30,wholesalers 49,retailers 74 and customers 147. 
 
Table 2.  Channel Performance of Vertical Marketing System of Drugs Distribution in Abia State, Nigeria. 
Indicators     No. of 
Respond
ents 
      na 
Scores  
Of  
Respond
ents 
Mean 
Scores 
  
    
   Xa 
Std 
Deviati
on       
 
  ∂ª 
No. of 
Respond
ents 
    
nb 
Scores of 
Respond
ents 
Mean 
scores   
 
 
  Xb 
Std 
Deviati
on  
 
∂b 
Total 
Respond
ents  
       
n 
Brand equity  160 720 4.50 11.32 140 560 4.00 5.31 300 
Prompt Drugs 
Delivery 
188 414 2.20 11.94 112 515 4.60 1.67 300 
Internal 
communication  
178 694 3.90 8.78 122 488 4.00 0.85 300 
Relative prices 133 519 3.90 5.07 167 334 2.00 12.68 300 
Profitability 178 392 2.20 13.92 122 561 4.60 5.78 300 
Innovation  174 696 4.00 9.03 126 554 4.40 5.06 300 
Channel 
Relationship 
185 555 3.00 1.64 115 552 4.80 5.11 300 
Market  Share 157 628 4.00 4.06 143 415 2.90 6.91 300 
Total 1353 4618 27.70 65.76 1047 3979 31.30 43.37 2400 
Aggregate Mean 169  577.25 3.46 8.22 131  497.38 3.91 5.42 300 
   Source: Field survey, 2013 
The analysis of the questionnaire provided the data in Table 2.Applying the Z statistical techniques to analyze 
the data for the testing of hypothesis one, the results were presented in Table 3. The degrees of freedom are equal 
to the total number of items sampled minus the number of samples (Lind, Marchal and Swathen, 2005: 367). For 
this study, the degrees of freedom are 8 – 4 = 4.  
Table 3.   Test of hypothesis   on channel performance of the vertical marketing system of drugs distribution . 
Respondent
s Category  
 
 
N 
 
 
X 
 
Standard  
Deviation 
Degrees of 
Freedom 
  Z 
Calculated 
   Z 
Critical 
  Level of 
Significance  
 
Decision 
  A 169 3.46 8.22  
     4 
 
 
- 0.41 
 
 
   1.96 
 
 
     0.05 
 
Accepted 
 
   B 131 3.91 
 
5.42 
 
Source: Field Survey, 2013. 
The respondents were categorized as A and B based on their perceptions (Table 3). Opinions on Strongly Agree 
and Agree came under category A while Undecided, Disagree and Strongly Disagree responses were assigned to 
B for purposes of clarity.The results of  the analysis using Z Statistical techniques were presented in Table 3. 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.12, 2013 
 
196 
 
     Hypothesis one (Decision): Ho- The channel performance of the vertical marketing system of drugs 
distribution in Abia State is not significantly high. Table 3 showed that the calculated   Z - value (-0.41) was 
found in the region between -1.96 and + 1.96 (i.e., critical values of Z), at 4 degrees of freedom and 0.05 level of 
significance. The null hypothesis was not rejected. The p-value provided a confirmation of this decision. The 
likelihood of finding a Z-value greater than -0.41 was 0.5000-0.1591= 0.3409.Being a two-tailed test, the p-
value, 2(0.3409) =0.6818, was greater than the significance level of 0.05(i.e. p >0.05). We therefore conclude 
that the performance of the vertical marketing system of drugs distribution in Abia State was not significantly 
high. 
Table 4. Channel Members’ Satisfaction with the Channel Linkage. 
Metrics      No. of 
Respond
ents  
 
 
      na 
Scores  
Of  
Respon
dents 
Mean 
Scores 
 
 
Xa 
Std 
Deviati
on 
 
 
  ∂a 
No. of 
Respondents 
      
 
      nb 
Scores of 
Respond
ents 
Mean 
scores  
 
 
 
  Xb 
Std 
Deviati
on  
 
 
∂b 
Total 
Respon
dents  
    
 
   n 
Prompt payment  150 660 4.40 4.82 150 660 4.40 6.16 300 
Credit 
Provisions 
136 571 4.20 2.59 164 426 2.60 12.43 300 
Mutual 
dependence  
108 443 4.10 15.29 192 768 4.00 13.26 300 
Drug return 
Policy 
136 653 4.80 4.46 164 476 2.90 8.52 300 
Avoidance of 
multiplicity of 
middle men  
180 810 4.50 15.61 122 573 4.70 1.07 300 
Sales force 
training 
143 586 4.10 1.61 157 565 3.60 1.58 300 
Reduction of 
dysfunctional 
conflicts 
122 488 4.00 10.28 178 587 3.30 0.03 300 
Order processing  122 598 4.90 0.28 178 623 3.50 2.88 300 
Total 1097 4809 35.00 54.94 1305 4678 29.00 45.93 2400 
Aggregate mean 137 601.13 4.38 6.87 163 584.75 3.63 5.74 300 
Source: Field survey, 2013 
The  data generated  for the testing of hypothesis two ,using Z statistical techniques were presented  in Table 
4.The metrics  provided parameters for  measuring  channel  members’ satisfaction with the channel linkage. 
Table 5. Test of hypothesis on channel members’ satisfaction with the distribution channel linkage.  
Respondents 
category  
 
 
N 
 
 
X 
Standard  
Deviation 
Degrees 
  of 
freedom 
 Z  - 
Calculated 
  Z  - 
Critical 
  Level 
    of 
significance  
 
Decision 
A 137 4.38 6.87  
   4 
 
 
+ 0.72 
 
 
  1.96 
 
 
    0.05 
 
Accepted 
 B 163 3.63 5.74 
    Source: Field Survey, 2013. 
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The results of the analysis of the responses on channel members’ satisfaction with the channel linkage using Z 
statistical techniques were presented in Table 5. 
Hypothesis two (Decision):Ho- The extent of channel members’ satisfaction with the distribution channel 
linkage is not significant to facilitate co-operation among members. Table 5 indicated that the calculated Z – 
value (+0.72) was found in the region between -1.96 and +1.96 (i.e., critical values of Z), at 0.05 level of 
significance and 4 degrees of freedom. In applying the decision rule, the null hypothesis was not rejected. The 
additional insight into the decision provided by p-value showed that the probability of finding Z-values as 
extreme as +0.72 was 0.5000-0.2642=0.2358.The two tailed p-value, 2(0.2358) =0.4716, was greater than the 
significance level of 0.05(i.e. p >0.05). The result implied that channel members’ do not derive significant 
satisfaction from the manufacturer – wholesaler- retailer- customer distribution channel linkage. We therefore 
uphold the null hypothesis that the extent of channel members’ satisfaction with the distribution channel linkage 
was not significant to facilitate co-operation among members of the channel.  
5.Discussionof the Results.     
 The findings of the study showed that the channel performance of the vertical marketing system of drugs 
distribution in Abia State was not significantly high. Interviews held with channel members corroborated the 
findings. Each channel member perceived another as an adversary engaged in behaviors designed to scuttle his 
efforts and gain scare resources at his expense. The manufacturers bypass the wholesalers and sell direct to 
retailers/ consumers. Wholesalers are denied easy access to the essential drugs and information on availability of 
new stocks. The middlemen are selfish, exploitative and neither care for the consumers nor the producers. They 
are interested in maximizing profits. A wholesaler or retailer procures drugs from the manufacturer or importer 
and sells them to the consumers, with little or no obligation to the manufacturer/importer, in spite of his huge 
financial resources. Feedbacks about market conditions are rarely sent to manufacturers to enhance innovations. 
Channel relationship is a far cry as the existing channel is largely an open market operation. The finding also 
revealed that the extent of channel members’ satisfaction with the distribution channel Linkage was not 
significant to facilitate co-operation among members of the channel. This implied that channel members do not 
derive significant satisfaction from the Manufacturer – Wholesaler- Retailer- Customer Channel Linkage as to 
facilitate channel co-operation. In reality, what exists between drug channel members in Abia State, appeared to 
be arm’s length transaction. The drug distributors serve price-sensitive customers in markets where there is 
strong upward pressures on costs (resulting from poor transport system / bad road networks) coupled with 
multiplicity of middlemen, competing vigorously on prices. In an interview with Mr. Ayo, the Managing 
Director of Petsow Laboratories Limited, Aba (drug manufacturing firm), the pharmacist lamented that the cost 
of producing a tin of Paracetamol (1000 tablets) analgesic, ranges from N550 - N600. Yet a tin of Paracetamol 
(1000 tablets) was sold for N250 - N300 in Aba drug market. The intense rivals and competition adversely 
affected growth in market shares of channel members with weak strength. While the big firms fully endowed 
with management resources are growing big, small firms are scratching for survival. Channel profitability is 
seriously eroded, resulting to abysmal performance of the vertical marketing system of drug distribution. The 
failure of a manufacturer or any other channel member to perform his task without guile hindered channel 
relationship. Manufacturers and institutional customers are often larger than distributors and have enormous 
resources. The inability of these big firms to provide necessary incentives to other channel members in the area 
of credits, prompt payment of commissions / discounts / rebates, quick order processing, sales force training and 
functional drug return schedules, brand equity among others, created dissatisfaction among members of the 
channel. The survey revealed that some channel members often engaged in withholding or distorting information 
to mislead, obfuscate or confuse others. This threat to free flow of information made dysfunctional conflicts 
inevitable within the system and affect channel performance. Opportunism whittles down goals compatibility 
and cooperation of the  channel members. Opportunism refers to a lack of candor or honesty in transactions to 
include self-interest seeking with guile (Willianson 1975: 9 cited in Brown, Dev. And Jin-lee, 2000: 51-65). A 
drug channel member behaves opportunistically to increase his short- term, unilateral gains. Opportunism is 
capable of eroding the long – term gains potentially accruing to members in a dyadic channel relationship. The 
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restraint of opportunism is critical to enhancing both channel performance and channel members’ satisfaction 
(Gassenheimer, Baucus and Baucus, 1996: 67-69). Drug damage and expired drugs provide the means for 
channel members to be opportunistic. They are sources of growing acrimony in the drug distribution channel 
between the manufacturers / importers and other channel members. Distributors blame manufacturers with 
respect to transportation accidents, package design flaws, late arrival of shipment or default in delivery 
arrangements. Manufacturers, in turn, blame distributors in the area of drugs damage at warehouse, store or 
damage in between and selling expired drugs instead of destroying them. The situation usually ends up affecting 
channel coordination / relationship and the size of the total channel profits, with low channel performance as the 
outcome. 
5.1Conclusion                                                                                                                                                                             
The low performance of the vertical marketing system of drugs distribution in Abia State and the dissatisfaction 
of the channel members with the distribution channel linkage were the findings of the study. The research 
findings confirmed the observation of Professor Dora Akunyili (former Director-General of National Agency For 
Food And Drugs Administration and Control, NAFDAC) that the drugs distribution system in Nigeria is rather 
chaotic (Akunyili, 2010: 219).The distributive trade is a sector that has not enjoyed a clear cut distribution policy 
by government (Chukwu, 2004:320).The virtually non-existent policy on distribution has contributed to the 
multiplicity and duplication of distribution functions in Nigeria. Channel members have not fully embraced the 
distribution channel as a system. There is neither channel co-operation nor channel relationship in strict terms. 
Opportunistic behaviors of channel members for short-term, unilateral gains abound. They are competing 
intensely on prices and the likelihood of customers switching distributors for lower prices is a surefire. 
Manufacturers and institutional customers with enormous resources to offer assistance to other channel members 
are shirking from the responsibilities. The problems of the small channel members should be seen as channel 
problem that can affect the overall channel performance. The prospects of those small firms for survival, profits 
and market share growth depend on good channel performance. Drugs are marketed like any other products. The 
Patent and Proprietary Medicine Dealers (PPMD) are in the business of drugs distribution and sale. Some are 
third generation drug sellers who were hawking drugs in luxury buses, with little or no formal education but 
simply learnt the skill on the job. They render services to Nigerians in the remote villages that have no access to 
pharmacists or medical doctors. They purchase drugs from available sources including illegal wholesale drug 
markets scattered all over the cities.  Efforts of NAFDAC authorities to create orderly marketing channels for 
drug distribution in Nigeria in general and Abia State in particular had suffered grave set back (Akunyili 2010: 
219). 
5.2 Recommendations. 
In view of the findings of the study, the following recommendations were made to enhance efficiency of the 
vertical marketing system of drugs distribution in Abia State for improved channel performance. 
1. Since the drug manufacturers / importers and institutional customers in Abia State are fully endowed with 
management resources. They should provide assistance to other channel members in training / retraining of 
personnel, particularly in key functional areas like marketing, finance and administration to raise their level 
of management expertise. The channel members would be equipped to understand the total channel concept, 
perform their respective tasks, discover their strengths / weaknesses and appropriate  responsibilities with 
finese, to enhance the efficiency of the vertical marketing system. 
2. Mutual dependence of channel members should be embraced with much interest, especially in matters of 
financial leverage. Manufacturers should extend generous credits provisions to other channel members 
while the wealthy distributors should make substantial financial deposits available to manufacturers to 
enable them attain economies of scale in production with the attendant cost- effectiveness. Channel 
members should pay promptly for drugs supplied or build the costs of indebtedness into interest charge or 
price structure. The emerging profitability of this financial arrangement would foster beneficial relationship 
and stimulate channel members’ satisfaction with the channel linkage. 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.12, 2013 
 
199 
 
3. Manufacturers / importers of drugs are encouraged to ease competitive conditions within the channel by 
limiting to a manageable proportion, the number of middlemen in a given territory. Emphasis should be 
centered on improving channel performance through the provision of relative prices, prompt delivery of 
drugs, promotional support, and growth in market shares and innovations in technology in relation to 
inventory computerization, telemarketing and video catalogues. 
4. Maintaining effective channel communication in the vertical marketing system of drugs distribution is 
imperative. Drug manufacturers need to gather market-place information on competitors’ pricing tactics, key 
factors hurting sales of particular brands of drugs, and how to co-ordinate wholesale and retail activities 
creditably. They need to give advance notice of  late arrival of shipment to control the number of “out-of-
stocks” of other channel members. New drugs and notice of upcoming special allowances should be 
communicated within the channel. The wholesalers and retailers need free information flow to enable them 
assist in coordinating national advertising of chain operations and utilize manpower development 
programmes of channel leaders. Retailers need information on how to locate potential customers, break 
bulk, sort and repackage drugs in smaller units, and position them to maximize shelf space to meet retail 
demand. With effective internal communication network of this nature, channel performance of the vertical 
marketing system of drugs distribution in Abia State would be enhanced.   
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